Net profit of Shree Ganesh Biotech India rose 300.00% to Rs 0.32 crore in the quarter ended September 2024 as against Rs 0.08 crore during the previous quarter ended September 2023. Sales declined 51.94% to Rs 1.98 crore in the quarter ended September 2024 as against Rs 4.12 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1.984.12 -52 OPM %1.011.94 - PBDT0.320.08 300 PBT0.320.08 300 NP0.320.08 300 Powered by Capital Market - Live News

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live News

Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live News

Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live News

Net profit of Shree Ganesh Biotech India rose 60.00% to Rs 0.24 crore in the quarter ended June 2024 as against Rs 0.15 crore during the previous quarter ended June 2023. Sales declined 56.85% to Rs 3.56 crore in the quarter ended June 2024 as against Rs 8.25 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.568.25 -57 OPM %-3.651.82 - PBDT0.240.15 60 PBT0.240.15 60 NP0.240.15 60 Powered by Capital Market - Live News